Control of a human tumour (ewing sarcoma) in mice by a single lethal dose of dimethyl-myleran and bone marrow
- 15 June 1981
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 27 (6) , 743-748
- https://doi.org/10.1002/ijc.2910270603
Abstract
A Ewing sarcoma grown in immunosuppressed mice was eradicated with a single lethal dose of dimethylmy-leran (DMM) followed by autologous or syngeneic bone marrow. Sarcomas treated 2 weeks after grafting in a phase of rapid proliferation disappeared and large sarcomas treated after 6 or 10 weeks were reduced to necrotic tissue. A human osteosarcoma also regressed distinctly after this therapy while a human colon carcinoma responded poorly. Sub-lethal DMM treatment induced complete remissions in only 62% of the mice. Tumours which display sensitivity in this model may be treated clinically with lethal doses of DMM and autologous marrow transplantions.This publication has 13 references indexed in Scilit:
- GROWTH OF HUMAN TUMORS IN MICE AFTER SHORT-TERM IMMUNOSUPPRESSION WITH PROCARBAZINE, CYCLOPHOSPHAMIDE, AND ANTILYMPHOCYTE SERUMTransplantation, 1980
- HÆMOPOIETIC RECOVERY IN EWING'S SARCOMA AFTER INTENSIVE COMBINATION THERAPY AND AUTOLOGOUS MARROW INFUSIONThe Lancet, 1980
- IN-VITRO CLONOGENIC ASSAY FOR PREDICTING RESPONSE OF OVARIAN CANCER TO CHEMOTHERAPYThe Lancet, 1980
- Immunodeficient Animals for Cancer ResearchPublished by Springer Nature ,1980
- Improved immune-suppression techniques for the xenografting of human tumoursBritish Journal of Cancer, 1978
- Use of Dimethylmyleran in Adoptive Chemoimmunotherapy of Two Murine Leukemias 2JNCI Journal of the National Cancer Institute, 1976
- Treatment of a mouse lymphoma by L‐asparaginase: Success depends on the host's immune responseInternational Journal of Cancer, 1973
- Bone-marrow Transplantation after Antilymphocytic Serum and Lethal ChemotherapyNature, 1969
- TREATMENT OF MOLONEY LYMPHOMA WITH LETHAL DOSES OF DIMETHYL-MYLERAN COMBINED WITH INJECTIONS OF HÆMOPOIETIC CELLSThe Lancet, 1969
- Wiederherstellung der Hämatopoese nach letaler Dosis von Dimethyl-Myleran durch isologe Knochenmarktransplantation bei Mäusen. Versuche zur Beeinflussung der Intoleranz gegenüber homologem Knochenmark durch 6-Mercaptopurin, Aminochlorambucil und CortisonActa Haematologica, 1961